Western blot analysis of SARS-CoV-2 S1 protein (His- tagged) (GenScript, Z03485) using S1 Antibody(GenScript, A02053).
Lane 1: 10 ng of Z03485
Lane 2: 5ng of Z03485
Western blot analysis of SARS-CoV-2 S1 protein (His- tagged) (GenScript, Z03485) using His Antibody (GenScript, A00186).
Lane 1: 10 ng of Z03485
Lane 2: 5ng of Z03485
1: 2 μg of S1, reducing (R)
2: 2 μg of S1, non-reducing (N)
> 85% as analyzed by SDS-PAGE
Synonyms | SARS-CoV-2 S1 protein(His-tagged) ;2019-nCoV S1 protein(His-tagged) |
Description | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. S protein plays an important role in the induction of neutralizing-antibodies and T-cell responses, as well as protective immunity. |
Species | SARS-CoV-2 |
Source | Human Cells |
Tag | His tag |
Biological Activity | SARS-CoV-2 Spike protein (S1) can bind with Human ACE2 in functional ELISA assay. |
Molecular Weight | Predicted molecular weight: ~79 KD |
Purity | > 85% as analyzed by SDS-PAGE |
Formulation | Liquid |
Component | PBS, pH 7.2,10% Glycerol |
Storage | The product can be stored at -20°C or below. Avoid repeated freezing and thawing cycles. The shelf life of the product is unspecified. |
Note | For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden. |
Western blot analysis of SARS-CoV-2 S1 protein (His- tagged) (GenScript, Z03485) using S1 Antibody(GenScript, A02053).
Lane 1: 10 ng of Z03485
Lane 2: 5ng of Z03485
Western blot analysis of SARS-CoV-2 S1 protein (His- tagged) (GenScript, Z03485) using His Antibody (GenScript, A00186).
Lane 1: 10 ng of Z03485
Lane 2: 5ng of Z03485
1: 2 μg of S1, reducing (R)
2: 2 μg of S1, non-reducing (N)
> 85% as analyzed by SDS-PAGE
For more documents, please visit "Technical Support".